Display options
Cite
Watson RR, Huls A, Araghinikuam M, et al. Dehydroepiandrosterone and diseases of aging. Drugs Aging. 1996;9(4):274-91doi: 10.2165/00002512-199609040-00005.
Watson, R. R., Huls, A., Araghinikuam, M., & Chung, S. (1996). Dehydroepiandrosterone and diseases of aging. Drugs & aging, 9(4), 274-91. https://doi.org/10.2165/00002512-199609040-00005
Watson, R R, et al. "Dehydroepiandrosterone and diseases of aging." Drugs & aging vol. 9,4 (1996): 274-91. doi: https://doi.org/10.2165/00002512-199609040-00005
Watson RR, Huls A, Araghinikuam M, Chung S. Dehydroepiandrosterone and diseases of aging. Drugs Aging. 1996 Oct;9(4):274-91. doi: 10.2165/00002512-199609040-00005. PMID: 8894525.
Copy Download .nbib Format: NLM
Share it on
Full text links
Springer

Drugs Aging. 1996 Oct;9(4):274-91. doi: 10.2165/00002512-199609040-00005.

Dehydroepiandrosterone and diseases of aging.

Drugs & aging

R R Watson, A Huls, M Araghinikuam, S Chung

Affiliations

  1. Arizona Prevention Center, University of Arizona, School of Medicine, Tucson, USA. [email protected]

PMID: 8894525 DOI: 10.2165/00002512-199609040-00005

Abstract

Dehydroepiandrosterone (DHEA; prasterone) is a major adrenal hormone with no well accepted function. In both animals and humans, low DHEA levels occur with the development of a number of the problems of aging: immunosenesence, increased mortality, increased incidence of several cancers, loss of sleep, decreased feelings of well-being, osteoporosis and atherosclerosis. DHEA replacement in aged mice significantly normalised immunosenescence, suggesting that this hormone plays a key role in aging and immune regulation in mice. Similarly, osteoclasts and lymphoid cells were stimulated by DHEA replacement, an effect that may delay osteoporosis. Recent studies do not support the original suggestion that low serum DHEA levels are associated with Alzheimer's disease and other forms of cognitive dysfunction in the elderly. As DHEA modulates energy metabolism, low levels should affect lipogenesis and gluconeogenesis, increasing the risk of diabetes mellitus and heart disease. Most of the effects of DHEA replacement have been extrapolated from epidemiological or animal model studies, and need to be tested in human trials. Studies that have been conducted in humans show essentially no toxicity of DHEA treatment at dosages that restore serum levels, with evidence of normalisation in some aging physiological systems. Thus, DHEA deficiency may expedite the development of some diseases that are common in the elderly.

Cited by

References

  1. Proc Soc Exp Biol Med. 1987 Dec;186(3):355-60 - PubMed
  2. Int J Obes. 1990 May;14(5):457-63 - PubMed
  3. Cancer Res. 1995 Sep 15;55(18):3949-53 - PubMed
  4. Cardiology. 1992;80(5-6):332-8 - PubMed
  5. J Clin Endocrinol Metab. 1992 Feb;74(2):362-7 - PubMed
  6. Anticancer Res. 1995 Mar-Apr;15(2):427-31 - PubMed
  7. Cancer Lett. 1992 Aug 14;65(2):123-6 - PubMed
  8. Circulation. 1992 Nov;86(5):1529-35 - PubMed
  9. J Clin Pharm Ther. 1990 Jun;15(3):213-9 - PubMed
  10. Biol Psychiatry. 1991 Oct 1;30(7):684-90 - PubMed
  11. J Clin Endocrinol Metab. 1993 Jul;77(1):80-5 - PubMed
  12. Proc Soc Exp Biol Med. 1991 Jan;196(1):8-16 - PubMed
  13. Br J Obstet Gynaecol. 1993 Dec;100(12):1115-9 - PubMed
  14. Diabetes. 1982 Sep;31(9):830-3 - PubMed
  15. Bone Miner. 1993 Feb;20(2):133-40 - PubMed
  16. Alcohol Clin Exp Res. 1993 Jun;17(3):539-44 - PubMed
  17. J Cell Biochem Suppl. 1993;17G:73-9 - PubMed
  18. J Nutr. 1988 Mar;118(3):382-7 - PubMed
  19. Cancer Res. 1991 Jan 15;51(2):481-6 - PubMed
  20. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1567-71 - PubMed
  21. Eur Urol. 1993;24 Suppl 2:94-105 - PubMed
  22. Ann Clin Biochem. 1990 Nov;27 ( Pt 6):557-61 - PubMed
  23. Lancet. 1995 May 13;345(8959):1193-4 - PubMed
  24. J Clin Endocrinol Metab. 1987 Jan;64(1):162-9 - PubMed
  25. J Clin Endocrinol Metab. 1993 Jun;76(6):1464-9 - PubMed
  26. Int J Obes. 1986;10(3):193-204 - PubMed
  27. J Clin Endocrinol Metab. 1989 Nov;69(5):1040-6 - PubMed
  28. Ann N Y Acad Sci. 1995 Dec 29;774:200-16 - PubMed
  29. J Nutr. 1989 Mar;119(3):496-501 - PubMed
  30. Atherosclerosis. 1976 Sep;24(3):471-81 - PubMed
  31. Int J Obes Relat Metab Disord. 1993 Nov;17(11):643-9 - PubMed
  32. Arch Virol. 1992;127(1-4):103-15 - PubMed
  33. Arch Surg. 1993 Mar;128(3):318-25 - PubMed
  34. Cardiovasc Clin. 1989;19(3):129-45 - PubMed
  35. J Clin Invest. 1988 Aug;82(2):712-20 - PubMed
  36. J Clin Endocrinol Metab. 1991 Oct;73(4):781-4 - PubMed
  37. Endocrinology. 1995 Feb;136(2):393-401 - PubMed
  38. Lancet. 1967 Sep 2;2(7514):485-7 - PubMed
  39. Prog Clin Biol Res. 1990;341A:791-6 - PubMed
  40. Life Sci. 1990;46(22):1627-31 - PubMed
  41. Am J Clin Nutr. 1994 Dec;60(6):831-6 - PubMed
  42. Nihon Naibunpi Gakkai Zasshi. 1986 May 20;62(5):672-82 - PubMed
  43. Anticancer Res. 1992 May-Jun;12(3):781-7 - PubMed
  44. J Clin Endocrinol Metab. 1987 Jan;64(1):180-4 - PubMed
  45. Cancer Res. 1991 Mar 1;51(5):1366-9 - PubMed
  46. J Exp Med. 1990 Apr 1;171(4):979-96 - PubMed
  47. J Clin Endocrinol Metab. 1990 Sep;71(3):696-704 - PubMed
  48. Ann N Y Acad Sci. 1994 May 31;719:553-63 - PubMed
  49. Eur J Immunol. 1990 Apr;20(4):793-802 - PubMed
  50. Eur J Cancer. 1976 Dec;12 (12 ):951-8 - PubMed
  51. Maturitas. 1989 Mar;11(1):65-73 - PubMed
  52. J Clin Endocrinol Metab. 1990 Dec;71(6):1653-7 - PubMed
  53. J Clin Endocrinol Metab. 1991 Apr;72(4):883-7 - PubMed
  54. J Androl. 1990 Sep-Oct;11(5):460-70 - PubMed
  55. Ann N Y Acad Sci. 1995 Dec 29;774:128-42 - PubMed
  56. J Am Coll Cardiol. 1990 Nov;16(6):862-70 - PubMed
  57. Ann N Y Acad Sci. 1995 Dec 29;774:297-9 - PubMed
  58. J Parasitol. 1992 Jun;78(3):554-7 - PubMed
  59. Ann N Y Acad Sci. 1995 Dec 29;774:73-81 - PubMed
  60. J Infect Dis. 1993 Apr;167(4):830-40 - PubMed
  61. J Clin Endocrinol Metab. 1990 Apr;70(4):1075-81 - PubMed
  62. J Clin Pathol. 1995 Jun;48(6):513-8 - PubMed
  63. Osteoporos Int. 1994 Mar;4(2):84-8 - PubMed
  64. Ann N Y Acad Sci. 1995 Dec 29;774:291-3 - PubMed
  65. J Am Geriatr Soc. 1990 Apr;38(4):421-7 - PubMed
  66. J Clin Endocrinol Metab. 1994 Jun;78(6):1360-7 - PubMed
  67. Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb;2(1):33-5 - PubMed
  68. J Parasitol. 1993 Jun;79(3):364-70 - PubMed
  69. J Lipid Res. 1968 Nov;9(6):769-72 - PubMed
  70. J Clin Endocrinol Metab. 1984 Sep;59(3):551-5 - PubMed
  71. Ann N Y Acad Sci. 1995 Dec 29;774:340-1 - PubMed
  72. Cancer Res. 1990 Oct 15;50(20):6571-4 - PubMed
  73. J Clin Endocrinol Metab. 1992 Jan;74(1):139-43 - PubMed
  74. J Clin Endocrinol Metab. 1988 Jan;66(1):57-61 - PubMed
  75. Circulation. 1994 Jan;89(1):89-93 - PubMed
  76. Metabolism. 1993 Oct;42(10):1284-90 - PubMed
  77. J Clin Endocrinol Metab. 1986 Apr;62(4):767-72 - PubMed
  78. Ann N Y Acad Sci. 1995 Dec 29;774:111-20 - PubMed
  79. Lancet. 1968 May 11;1(7550):1003-4 - PubMed
  80. Cancer Res. 1992 Jan 1;52(1):1-4 - PubMed
  81. Eur J Clin Invest. 1972 Jan;2(2):91-5 - PubMed
  82. J Clin Endocrinol Metab. 1990 Nov;71(5):1259-64 - PubMed
  83. J Clin Endocrinol Metab. 1991 Feb;72(2):272-6 - PubMed
  84. Cancer Epidemiol Biomarkers Prev. 1993 May-Jun;2(3):219-21 - PubMed
  85. J Acquir Immune Defic Syndr. 1992;5(8):841-6 - PubMed
  86. Ann N Y Acad Sci. 1994 May 31;719:564-75 - PubMed
  87. Cancer. 1985 Dec 1;56(11):2557-62 - PubMed
  88. Experientia. 1977 Jul 15;33(7):966-7 - PubMed
  89. Ann N Y Acad Sci. 1994 May 31;719:543-52 - PubMed
  90. Brain Res. 1988 May 10;448(1):178-81 - PubMed
  91. Epidemiol Rev. 1985;7:89-104 - PubMed
  92. Diabetes. 1991 Jun;40(6):693-700 - PubMed
  93. Am J Obstet Gynecol. 1993 Dec;169(6):1536-9 - PubMed
  94. Clin Endocrinol (Oxf). 1991 Jan;34(1):37-41 - PubMed
  95. Life Sci. 1992;51(25):1953-6 - PubMed
  96. J Clin Endocrinol Metab. 1988 Jun;66(6):1329-31 - PubMed
  97. Ann N Y Acad Sci. 1995 Dec 29;774:259-70 - PubMed
  98. Life Sci. 1996;59(11):PL147-57 - PubMed
  99. Anticancer Res. 1992 May-Jun;12(3):799-803 - PubMed
  100. Ann N Y Acad Sci. 1995 Dec 29;774:319-22 - PubMed
  101. JAMA. 1991 Feb 20;265(7):912 - PubMed
  102. Tumour Biol. 1993;14(1):38-45 - PubMed
  103. Adv Enzyme Regul. 1987;26:355-82 - PubMed
  104. J Clin Endocrinol Metab. 1990 Oct;71(4):900-6 - PubMed
  105. Atherosclerosis. 1994 Feb;105(2):191-200 - PubMed
  106. Exp Clin Endocrinol. 1993;101(4):222-9 - PubMed
  107. Neoplasma. 1994;41(2):101-3 - PubMed
  108. J Cell Biochem Suppl. 1995;22:210-7 - PubMed
  109. Psychol Med. 1996 Mar;26(2):245-56 - PubMed
  110. Ann N Y Acad Sci. 1995 Dec 29;774:329-31 - PubMed
  111. Am J Med Sci. 1993 Nov;306(5):320-4 - PubMed
  112. Ann N Y Acad Sci. 1995 Dec 29;774:271-80 - PubMed
  113. Cancer Res. 1990 Jul 1;50(13):3859-62 - PubMed
  114. Clin Nephrol. 1987 Apr;27(4):169-74 - PubMed
  115. Diabetes. 1994 Feb;43(2):212-9 - PubMed
  116. J Clin Endocrinol Metab. 1994 Mar;78(3):549-54 - PubMed
  117. Maturitas. 1990 Jun;12(2):137-43 - PubMed
  118. Am J Obstet Gynecol. 1992 Apr;166(4):1163-8; discussion 1168-70 - PubMed
  119. Diabetes. 1984 Jan;33(1):26-32 - PubMed
  120. Toxicol Pathol. 1987;15(2):164-9 - PubMed
  121. J Immunol. 1993 Jun 15;150(12):5219-30 - PubMed
  122. Nature. 1951 Jul 7;168(4262):28 - PubMed
  123. Metabolism. 1994 May;43(5):599-603 - PubMed
  124. Anticancer Res. 1993 Nov-Dec;13(6A):2267-72 - PubMed
  125. Eur J Immunol. 1989 Dec;19(12):2319-25 - PubMed
  126. Ann N Y Acad Sci. 1995 Dec 29;774:281-90 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources